Sector Charles River Laboratories International, Inc.
Aandelen
CRL
US1598641074
Biotechnologie & Medisch Onderzoek
|
Geschatte realtime
Cboe BZX
17:57:50 02-10-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 288,92 USD | +0,73% |
|
-1,63% | +44,41% |
| 30/09 | Charles River Laboratories International, Inc. : UBS stelt koopadvies voor | ZM |
| 29/09 | PMGC-divisie werkt samen met Charles River Laboratories aan tests van probiotica voor spiergezondheid | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,73% | -1,63% | -1,26% | +24,87% | +44,41% | +64,27% | +48,96% | -27,70% | +244,25% | 13,69 mld. | |
| +4,16% | +3,04% | +8,38% | +33,66% | +84,62% | +49,37% | +94,17% | +9,52% | - | 74,41 mld. | |
| -3,11% | -3,53% | -9,46% | -1,19% | +13,76% | +21,92% | +74,60% | +218,02% | +5.289,29% | 59,26 mld. | |
| +0,89% | -0,63% | -3,05% | +0,18% | +5,17% | +4,28% | +34,51% | -18,05% | +203,27% | 47,14 mld. | |
| -0,52% | -4,18% | -1,80% | +25,14% | +14,94% | +26,79% | +33,63% | +8,60% | +223,04% | 42,91 mld. | |
| +1,26% | +1,81% | -0,26% | +10,28% | +162,00% | +356,64% | +697,42% | +629,67% | - | 44,13 mld. | |
| -1,99% | -2,69% | -2,94% | +17,97% | +15,58% | +1,73% | +96,71% | -0,76% | +1.032,68% | 40,79 mld. | |
| -0,54% | +2,93% | -2,87% | +4,64% | +5,93% | +9,50% | +50,41% | -10,44% | +144,22% | 30,77 mld. | |
| -2,68% | +5,11% | +10,25% | +57,66% | +73,51% | +33,11% | +19,50% | -56,88% | - | 29,31 mld. | |
| +0,35% | -7,47% | -13,90% | -2,31% | -37,36% | -28,65% | +329,74% | +312,04% | +648,80% | 23,71 mld. | |
| +0,15% | -1,41% | -6,43% | -0,43% | +2,03% | -7,06% | -13,85% | -60,98% | - | 24,33 mld. | |
| -2,42% | -0,88% | +3,77% | +20,44% | +11,35% | +11,46% | -7,65% | -17,11% | +97,64% | 20,81 mld. | |
| +1,72% | -1,77% | +2,51% | +9,02% | +8,23% | +13,38% | +150,62% | +217,44% | +1.891,14% | 16,69 mld. | |
| -0,43% | +0,87% | -11,07% | -4,98% | +174,96% | +131,18% | +326,82% | +1.692,64% | +635,44% | 15,17 mld. | |
| -0,19% | +0,54% | -15,15% | -17,37% | - | - | - | - | - | 14,93 mld. | |
| -3,04% | +1,33% | -3,59% | +8,25% | +20,40% | -8,13% | +516,45% | - | - | 14,84 mld. | |
| +0,43% | -3,23% | +2,86% | +8,27% | +19,97% | +19,13% | +43,03% | -28,54% | +81,88% | 14,57 mld. | |
| +0,78% | -8,89% | +25,04% | +28,51% | +31,16% | -13,27% | - | - | - | 13,8 mld. | |
| +1,23% | +0,91% | +0,27% | +5,09% | +33,90% | +41,93% | +164,13% | +178,94% | +361,40% | 14,36 mld. | |
| +0,90% | +6,95% | +14,35% | +8,27% | -4,55% | -20,00% | +843,22% | +226,07% | +93,01% | 13,31 mld. | |
| Gemiddelde | -0,09% | -1,07% | -0,22% | +11,80% | +35,79% | +37,24% | +194,58% | +192,50% | +842,00% | 28,45 mld. | |
| Gewogen gemiddelde per kap. | +0,05% | -0,70% | -0,57% | +13,84% | +40,37% | +47,27% | +164,16% | +149,54% | +1.270,51% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
